Berberine inhibits Staphylococcus epidermidis adhesion and biofilm formation on the surface of titanium alloy

Journal of Orthopaedic Research

Volumn 27, Issue 11, 2009, Pages 1487-1492

  Wang, Xiaoqing ^a   Qiu, Shijing ^b   Yao, Xiao ^c   Tang, Tingting ^a   Dai, Kerong ^a   Zhu, Zhen'an ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b HENRY FORD HOSPITAL   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Adhesion; Berberine; Biofilm; Staphylococcus epidermidis; Titanium

Indexed keywords

BERBERINE; CRYSTAL VIOLET; TITANIUM;

ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BIOFILM; CHEMICAL STRUCTURE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; JOINT PROSTHESIS; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS INFECTION; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS EPIDERMIDIS;

ALLOYS; BACTERIAL ADHESION; BERBERINE; BIOFILMS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; PROSTHESES AND IMPLANTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; TITANIUM;

EID: 70350217494     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20917     Document Type: Article

References (39)

1. Bauer TW, Parvizi J, Kobayashi N, et al. 2006. Diagnosis of periprosthetic infection. J Bone Joint Surg Am 88:869-882.
2. Peersman G, Laskin R, Davis J, et al. 2001. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res 392:15-23. (Pubitemid 33054925)
3. Darouiche RO. 2004. Treatment of infections associated with surgical implants. N Engl J Med 350:1422-1429. (Pubitemid 38419996)
4. Zimmerli W, Trampuz A, Ochsner PE. 2004. Prosthetic-joint infections. N Engl J Med 351:1645-1654.
5. Sculco TP. 1993. The economic impact of infected total joint arthroplasty. Instr Course Lect 42:349-351.
6. von Eiff C, Peters G, Heilmann C. 2002. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2:677-685. (Pubitemid 35265063)
7. Holden M, Crossman L, Cerdeno-Tarraga A, et al. 2004. Pathogenomics of non-pathogens. Nat Rev Microbiol 2:91.
8. Vuong C, Otto M. 2002. Staphylococcus epidermidis infections. Microbes Infect/Institut Pasteur 4:481-489.
9. Okajima Y, Kobayakawa S, Tsuji A, et al. 2006. Biofilm formation by Staphylococcus epidermidis on intraocular lens material. Invest Ophthalmol Vis Sci 47:2971-2975. (Pubitemid 351639774)
10. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322. (Pubitemid 29289651)
11. Gristina AG. 1987. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 237:1588-1595. (Pubitemid 17134883)
12. Antoci V Jr, King SB, Jose B, et al. 2007. Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J Orthop Res 25:858-866. (Pubitemid 47046432)
13. Gilbert P, Das J, Foley I. 1997. Biofilm susceptibility to antimicrobials. Adv Dent Res 11:160-167.
14. Donlan RM. 2001. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33:1387-1392.
15. Donlan RM. 2002. Biofilms: microbial life on surfaces. Emerg Infect Dis 8:881-890.
16. Long M, Rack HJ. 1998. Titanium alloys in total joint replacement - a materials science perspective. Biomaterials 19:1621-1639. (Pubitemid 28512843)
17. Schildhauer TA, Robie B, Muhr G, et al. 2006. Bacterial adherence to tantalum versus commonly used orthopedic metallic implant materials. J Orthop Trauma 20:476-484. (Pubitemid 44197617)
18. Antoci V Jr, Adams CS, Parvizi J, et al. 2008. The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials 29:4684-4690.
19. Szymanska J. 2006. Bacterial decontamination of DUWL biofilm using Oxygenal 6. Ann Agric Environ Med 13:163-167.
20. Walker JT, Bradshaw DJ, Fulford MR, et al. 2003. Microbiological evaluation of a range of disinfectant products to control mixed-species biofilm contamination in a laboratory model of a dental unit water system. Appl Environ Microbiol 69:3327-3332.
21. Juda M, Paprota K, Jaloza D, et al. 2008. Edta as a potential agent preventing formation of Staphylococcus epidermidis biofilm on polichloride vinyl biomaterials. Ann Agric Environ Med 15:237-241.
22. Kadry AA, Fouda SI, Shibl AM, et al. 2009. Impact of slime dispersants and anti-adhesives on in vitro biofilm formation of Staphylococcus epidermidis on intraocular lenses and on antibiotic activities. J Antimicrob Chemo 63:480-484.
23. Aslam S. 2008. Effect of antibacterials on biofilms. Am J Infect Control 36:S175.e9-11.
24. Presterl E, Suchomel M, Eder M, et al. 2007. Effects of alcohols, povidone-iodine and hydrogen peroxide on biofilms of Staphylococcus epidermidis. J Antimicrob Chemo 60:417-420. (Pubitemid 47243897)
25. Wang X, Yao X, Zhu Z, et al. 2009. Effect of berberine on Staphylococcus epidermidis biofilm formation. Int J Antimicrob Agent (in press).
26. Arens S, Schlegel U, Printzen G, et al. 1996. Influence of materials for fixation implants on local infection. An experimental study of steel versus titanium DCP in rabbits. J Bone Joint Surg Br 78:647-651. (Pubitemid 26241770)
27. Ha KY, Chung YG, Ryoo SJ. 2005. Adherence and biofilm formation of Staphylococcus epidermidis and Mycobacterium tuberculosis on various spinal implants. Spine 30:38-43.
28. Mathur T, Singhal S, Khan S, et al. 2006. Detection of biofilm formation among the clinical isolates of Staphylococci: an evaluation of three different screening methods. Ind J Med Microbiol 24:25-29.
29. Sheehan E, McKenna J, Mulhall KJ, et al. 2004. Adhesion of Staphylococcus to orthopaedic metals, an in vivo study. J Orthop Res 22:39-43. (Pubitemid 38035443)
30. Schmidmaier G, Lucke M, Wildemann B, et al. 2006. Prophylaxis and treatment of implant-related infections by antibioticcoated implants: a review. Injury 37(Suppl 2):S105-112.
31. Marculescu CE, Osmon DR. 2005. Antibiotic prophylaxis in orthopedic prosthetic surgery. Infect Dis Clin North Am 19:931-946.
32. Trampuz A, Widmer AF. 2006. Infections associated with orthopedic implants. Curr Opin Infect Dis 19:349-356.
33. Wang D, Yu L, Xiang H, et al. 2008. Global transcriptional profiles of Staphylococcus aureus treated with berberine chloride. FEMS Microbiol Lett 279:217-225. (Pubitemid 351164873)
34. Cernakova M, Kostalova D. 2002. Antimicrobial activity of berberine-a constituent of Mahonia aquifolium. Folia Microbiol 47:375-378. (Pubitemid 135695736)
35. Kim SH, Shin DS, Oh MN, et al. 2004. Inhibition of the bacterial surface protein anchoring transpeptidase sortase by isoquinoline alkaloids. Biosci Biotechnol Biochem 68:421-424.
36. Yang K, Yeo SJ, Lee BP, et al. 2001. Total knee arthroplasty in diabetic patients: a study of 109 consecutive cases. J Arthroplasty 16:102-106. (Pubitemid 32097236)
37. Bolognesi MP, Marchant MH Jr, Viens NA, et al. 2008. The impact of diabetes on perioperative patient outcomes after total hip and total knee arthroplasty in the United States. J Arthroplasty 23:92-98.
38. Lee YS, Kim WS, Kim KH, et al. 2006. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55:2256-2264.
39. Zhang Y, Li X, Zou D, et al. 2008. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab 93:2559-2565. (Pubitemid 352008520)